Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Kwang W. Ahn"'
Autor:
Mazyar Shadman, Kwang W. Ahn, Manmeet Kaur, Lazaros Lekakis, Amer Beitinjaneh, Madiha Iqbal, Nausheen Ahmed, Brian Hill, Nasheed M. Hossain, Peter Riedell, Ajay K. Gopal, Natalie Grover, Matthew Frigault, Jonathan Brammer, Nilanjan Ghosh, Reid Merryman, Aleksandr Lazaryan, Ron Ram, Mark Hertzberg, Bipin Savani, Farrukh Awan, Farhad Khimani, Sairah Ahmed, Vaishalee P. Kenkre, Matthew Ulrickson, Nirav Shah, Mohamed A. Kharfan-Dabaja, Alex Herrera, Craig Sauter, Mehdi Hamadani
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-7 (2024)
Abstract In patients with relapsed DLBCL in complete remission (CR), autologous hematopoietic cell transplantation (auto-HCT) and CAR-T therapy are both effective, but it is unknown which modality provides superior outcomes. We compared the efficacy
Externí odkaz:
https://doaj.org/article/e8520ed8a9ea4ad4a6eebc0252da84a4
Autor:
Matthew Mei, Mehdi Hamadani, Kwang W. Ahn, Yue Chen, Mohamed A. Kharfan-Dabaja, Craig Sauter, Alex F. Herrera
Publikováno v:
Haematologica, Vol 107, Iss 5 (2022)
Externí odkaz:
https://doaj.org/article/43a18a79f2ea44fcb1fc77bf038fa2b4
Autor:
Narendranath Epperla, Kwang W. Ahn, Carlos Litovich, Sairah Ahmed, Minoo Battiwalla, Jonathon B. Cohen, Parastoo Dahi, Nosha Farhadfar, Umar Farooq, Cesar O. Freytes, Nilanjan Ghosh, Bradley Haverkos, Alex Herrera, Mark Hertzberg, Gerhard Hildebrandt, David Inwards, Mohamed A. Kharfan-Dabaja, Farhad Khimani, Hillard Lazarus, Aleksandr Lazaryan, Lazaros Lekakis, Hemant Murthy, Sunita Nathan, Taiga Nishihori, Attaphol Pawarode, Tim Prestidge, Praveen Ramakrishnan, Andrew R. Rezvani, Rizwan Romee, Nirav N. Shah, Ana Sureda, Timothy S. Fenske, Mehdi Hamadani
Publikováno v:
Journal of Hematology & Oncology, Vol 12, Iss 1, Pp 1-11 (2019)
Abstract Background There is a paucity of data on the role of allogeneic hematopoietic cell transplantation (allo-HCT) in patients with angioimmunoblastic T-cell lymphoma (AITL). Using the CIBMTR registry, we report here the outcomes of AITL patients
Externí odkaz:
https://doaj.org/article/19ce45d9a24347588db685661d8cf472
Autor:
Fateeha Furqan, Kwang W. Ahn, Yue Chen, Manmeet Kaur, Syed A. Abutalib, Nausheen Ahmed, Sairah Ahmed, Mohamed A. Kharfan‐Dabaja, Johnathan Friedberg, Tara Gregory, LaQuisa Hill, Cole Sterling, Stephan K. Barta, Mazyar Shadman, Miguel‐Angel Perales, Jasmine Zain, Alex F. Herrera, Craig Sauter, Mehdi Hamadani
Publikováno v:
British Journal of Haematology. 200:54-63
The prognosis of relapsed/refractory (R/R) anaplastic large cell lymphoma (ALCL) is poor. Large studies evaluating outcomes of allogeneic haematopoietic cell transplantation (allo-HCT) in systemic R/R ALCL are not available. Using the Center for Inte
Autor:
Michael A. Pulsipher, Kwang W. Ahn, Nancy J. Bunin, Nahal Lalefar, Eric Anderson, Allyson Flower, Mitchell S. Cairo, Julie-An Talano, Sonali Chaudhury, Carrie L. Kitko, Jamie L. Duke, Dimitrios Monos, Wing Leung, Christopher C. Dvorak, Hisham Abdel-Azim
Publikováno v:
Blood. 140(24)
We performed a prospective multicenter study of T-cell receptor αβ (TCR-αβ)/CD19–depleted haploidentical hematopoietic cell transplantation (HCT) in children with acute leukemia and myelodysplastic syndrome (MDS), to determine 1-year disease-fr
Autor:
Pashna N. Munshi, Yue Chen, Kwang W. Ahn, Farrukh T. Awan, Amanda Cashen, Geoffrey Shouse, Mazyar Shadman, Paul Shaughnessy, Joanna Zurko, Frederick L. Locke, Aaron M. Goodman, Jose C. Villaboas Bisneto, Craig Sauter, Mohamad A. Kharfan-Dabaja, Gabrielle Meyers, Samantha Jaglowski, Alex Herrera, Mehdi Hamadani
Publikováno v:
Transplantation and cellular therapy. 28(8)
Data for outcomes after autologous hematopoietic cell transplantation (auto-HCT) in diffuse large B-cell lymphoma (DLBCL) patients ≥70 years are limited. Auto-HCT is feasible in older DLBCL patients. Using the Center for International Blood and Mar
Autor:
Malvi Savani, Kwang W. Ahn, Yue Chen, Sairah Ahmed, Amanda F. Cashen, Mazyar Shadman, Dipenkumar Modi, Farhad Khimani, Corey S. Cutler, Jasmine Zain, Jonathan E. Brammer, Andrew R. Rezvani, Timothy S. Fenske, Craig S. Sauter, Mohamed A. Kharfan‐Dabaja, Alex F. Herrera, Mehdi Hamadani
Publikováno v:
Br J Haematol
There have been no large studies comparing reduced-intensity/non-myeloablative conditioning (RIC/NMA) to myeloablative conditioning (MAC) regimens in T-cell non-Hodgkin lymphoma (T-NHL) patients undergoing allogeneic transplant (allo-HCT). A total of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78cdee94c0ce8dee35d0632ad0091a4a
https://europepmc.org/articles/PMC9018546/
https://europepmc.org/articles/PMC9018546/
Autor:
Matthew Mei, Mehdi Hamadani, Kwang W. Ahn, Yue Chen, Mohamed A. Kharfan-Dabaja, Craig Sauter, Alex F. Herrera
Publikováno v:
Haematologica. 107(5)
Autor:
Claudio Brunstein, Mary Eapen, Kwang w Ahn, Frederick R. Appelbaum, Karen K Ballen, Richard Champlin, Fangyu Kan, Mary J. Laughlin, Robert J Soiffer, Daniel J. Weisdorf, Ann Woolfrey, Mary M. Horowitz, John E. Wagner
Publikováno v:
Blood. 116:908-908
Abstract 908 Peripheral blood progenitor cells (PBPC) are the preferred graft source for RIC transplantation. As in other settings, if a suitable unrelated adult donor is not available, primarily HLA mismatched unrelated cord blood (CB) is increasing